ClinicalTrials.gg
Not yet recruitingNCT07942870Updated Nov 17, 2026

Superior Trunk Block Versus Combined Suprascapular and Axillary Nerve Blocks

An interventional study of Superior Trunk Block and Combined Suprascapular and Axillary Nerve Blocks in Shoulder Pain and Postoperative Pain, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Assiut University · Not applicable, Interventional, and Prevention

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 10 studies in Shoulder Pain by Assiut University — 7 open to participants now, 7 under way, none of them phase 3. Shoulder Pain · Assiut University.

Started
2026
with 1 other
No phase
7 of 10
6 open now
Registered
11th of 10
by date

Among the 10 studies in Shoulder Pain by Assiut University, this one is one of 2 that started in 2026, is one of 7 with no phase, and was the 11th registered.

Shoulder Pain

736 studies on the registry are indexed under Shoulder Pain; 166 are open to participants now.

Browse Shoulder Pain studies →

Open to participants now

7 of the 10 studies in Shoulder Pain by Assiut University are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 89 Shoulder Pain studies recruiting now, 24 (27%) set no upper age limit and 55 (62%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Shoulder Pain by Assiut University, or all of them as a file.
02

Study summary

This randomized controlled trial aims to compare the effects of ultrasound-guided superior trunk block versus combined suprascapular and axillary nerve blocks on diaphragmatic function and postoperative analgesia in patients undergoing arthroscopic shoulder surgery.

Read the detailed description

Arthroscopic shoulder surgery is associated with significant postoperative pain. The interscalene brachial plexus block is effective but carries a risk of hemidiaphragmatic paralysis.

The superior trunk block targets the C5-C6 roots after they form the superior trunk and aims to reduce phrenic nerve involvement. Combined blockade of the suprascapular and axillary nerves provides shoulder analgesia with potentially less diaphragmatic impact.

This study will randomize patients undergoing elective unilateral arthroscopic shoulder surgery to receive either ultrasound-guided superior trunk block or combined ultrasound-guided suprascapular and axillary nerve blocks, and will assess diaphragmatic function and postoperative pain.

03

Conditions studied

  • Shoulder Pain
  • Postoperative Pain

Keywords

  • Superior trunk block
  • Suprascapular nerve block
  • Axillary nerve block
  • Hemidiaphragmatic paralysis
  • Arthroscopic shoulder surgery
  • Assiut
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • physical status I-II
  • Age 18-65 years
  • Scheduled for elective unilateral arthroscopic shoulder surgery
  • Written

Exclusion criteria

Exclusion Criteria:

  • Patient refusal
  • Known allergy to local anesthetics
  • Pre-existing phrenic nerve palsy or diaphragmatic dysfunction
  • Severe
  • Coagulopathy or bleeding diathesis
  • Infection at the injection site
  • Pre-existing neurological deficit in the operative arm
  • Pregnancy or breastfeeding
  • greater than 35 kg/m²
  • Bilateral shoulder surgery
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Superior Trunk Block

    Patients will receive ultrasound-guided superior trunk block with 10 mL of 0.25% bupivacaine.

    Procedure: Superior Trunk Block

  • Active comparator
    Combined Suprascapular and Axillary Nerve Blocks

    Patients will receive combined ultrasound-guided suprascapular and axillary nerve blocks with 5 mL of 0.5% ropivacaine for each nerve (total 10 mL).

    Procedure: Combined Suprascapular and Axillary Nerve Blocks

Interventions

  • ProcedureSuperior Trunk Block

    Ultrasound-guided injection of local anesthetic around the superior trunk of the brachial plexus.

  • ProcedureCombined Suprascapular and Axillary Nerve Blocks

    Ultrasound-guided injection of local anesthetic around the suprascapular nerve and the axillary nerve.

06

What researchers measure

Primary outcomes

  1. Number of patients with hemidiaphragmatic paralysis

    Number of patients who develop hemidiaphragmatic paralysis assessed by ultrasound measurement of diaphragmatic excursion at 30 minutes after the block.

    Time frame: At 30 minutes after block

Secondary outcomes

  1. Diaphragmatic excursion

    Mean diaphragmatic excursion measured by ultrasound in centimeters during quiet breathing and deep inspiration.

    Time frame: At 30 minutes after block

  2. Pain score at rest

    Mean pain score at rest measured by numerical rating scale (range 0 to 10, higher scores indicate more pain).

    Time frame: At 24 hours

  3. Total opioid consumption

    Mean total opioid consumption in morphine milligram equivalents in the first 24 hours after surgery.

    Time frame: At 24 hours

  4. Time to first rescue analgesia

    Mean time from end of surgery to first request for rescue analgesia in hours.

    Time frame: At 24 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

Of 350 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 12 months is close to that.

Counting every sponsor, half of 355 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartEst.
Nov 26, 2026
Primary completionEst.
Nov 26, 2027
CompletionEst.
Mar 10, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942870
Lead sponsor
Assiut University
Responsible party
Tarek Ahmed Sayed (Resident Physician, Department of Anesthesia, Assiut University) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 26, 2026 (estimated)
Primary completion
Nov 26, 2027 (estimated)
Completion
Mar 10, 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Tarek A Sayed, Resident
Contact
Tarek.18313300@med.aun.edu.eg
0109876361
Samy A Amr, prof
study chair · Anaesthesia , ICU and pain management Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion